Lan Tang

4.9k total citations · 1 hit paper
169 papers, 3.8k citations indexed

About

Lan Tang is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Lan Tang has authored 169 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 34 papers in Pharmacology and 30 papers in Pharmacology. Recurrent topics in Lan Tang's work include Natural product bioactivities and synthesis (18 papers), Pharmacogenetics and Drug Metabolism (16 papers) and Pharmacological Effects of Natural Compounds (11 papers). Lan Tang is often cited by papers focused on Natural product bioactivities and synthesis (18 papers), Pharmacogenetics and Drug Metabolism (16 papers) and Pharmacological Effects of Natural Compounds (11 papers). Lan Tang collaborates with scholars based in China, United States and Hong Kong. Lan Tang's co-authors include Zhongqiu Liu, Ming Hu, Ling Ye, Zheng Cai, Jie Zhao, Menghua Liu, Xu Chen, Junxuan Fan, Rashim Singh and Xuefeng Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Lan Tang

164 papers receiving 3.8k citations

Hit Papers

Transplantation of fecal microbiota rich in short chain f... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Tang China 34 1.6k 886 607 438 382 169 3.8k
Yue Gao China 36 1.9k 1.1× 937 1.1× 332 0.5× 406 0.9× 620 1.6× 235 3.8k
Kwang‐Hyeon Liu South Korea 36 2.1k 1.3× 1.2k 1.3× 470 0.8× 400 0.9× 215 0.6× 188 4.8k
Zhong‐Ze Fang China 33 1.4k 0.9× 1.0k 1.1× 330 0.5× 228 0.5× 197 0.5× 168 3.2k
Huichang Bi China 37 1.9k 1.1× 1.3k 1.5× 319 0.5× 224 0.5× 312 0.8× 178 4.2k
Yun‐Feng Cao China 32 1.3k 0.8× 833 0.9× 420 0.7× 233 0.5× 204 0.5× 156 3.3k
Hua Chen China 44 2.8k 1.7× 542 0.6× 472 0.8× 304 0.7× 524 1.4× 173 6.0k
Xiaoyan Chen China 35 1.4k 0.9× 801 0.9× 654 1.1× 165 0.4× 187 0.5× 222 4.4k
Hui‐Jun Li China 35 2.0k 1.2× 731 0.8× 348 0.6× 993 2.3× 820 2.1× 191 3.9k
Yaping Liu China 43 2.4k 1.5× 2.0k 2.3× 995 1.6× 1.1k 2.5× 290 0.8× 311 7.1k
Xiaodong Liu China 30 1.1k 0.7× 736 0.8× 626 1.0× 238 0.5× 215 0.6× 164 3.1k

Countries citing papers authored by Lan Tang

Since Specialization
Citations

This map shows the geographic impact of Lan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Tang more than expected).

Fields of papers citing papers by Lan Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Tang. The network helps show where Lan Tang may publish in the future.

Co-authorship network of co-authors of Lan Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Tang. A scholar is included among the top collaborators of Lan Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Tang. Lan Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zehua, et al.. (2025). PBPK-PD model for predicting pharmacokinetics, tumor growth inhibition, and toxicity risks of topoisomerase inhibitor ADCs in mice and humans. European Journal of Pharmaceutical Sciences. 213. 107234–107234. 1 indexed citations
2.
Wang, Lin, Zhao Deng, Qian Yang, et al.. (2025). Investigating the main contributors to esterification activity and identifying the aqueous-phase ester synthases in Daqu. Food Bioscience. 66. 106227–106227. 6 indexed citations
3.
Xie, Danni, et al.. (2024). New Sesquiterpenoids from the Mangrove-Derived Fungus Talaromyces sp. as Modulators of Nuclear Receptors. Marine Drugs. 22(9). 403–403. 3 indexed citations
4.
Hu, Shiyu, Jia‐wen Zhou, Lan Tang, Yunfei Zhao, & Huige Xing. (2023). The impact of risk communication, trust, and coping appraisal on individual preparedness decisions in geological hazard-prone areas. International Journal of Disaster Risk Reduction. 100. 104166–104166. 6 indexed citations
5.
Zhang, Lijuan, et al.. (2023). A nomogram for predicting the 4-year risk of chronic kidney disease among Chinese elderly adults. International Urology and Nephrology. 55(6). 1609–1617. 1 indexed citations
6.
Gao, Y, et al.. (2023). Preliminary exploration of inulin and inulin liposome on DSS-induced colitis remission. Journal of Drug Delivery Science and Technology. 88. 104911–104911. 1 indexed citations
7.
Liu, Wenqin, Fuling Wu, Xiaoli Bi, et al.. (2023). Herbal formula Jiawei Xiaochengqi decoction prevents postoperative abdominal adhesion in a rat model through inhibition of CXCL2-CXCR2 pathway. Phytomedicine. 111. 154662–154662. 12 indexed citations
8.
Tang, Lan, Wenhui Jiang, Lan Wu, et al.. (2021). TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy. International Journal of Nanomedicine. Volume 16. 7875–7890. 25 indexed citations
9.
Liu, Wenqin, Fei Qin, Fuling Wu, et al.. (2020). Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway. Phytomedicine. 69. 153193–153193. 15 indexed citations
10.
Lin, Yu, Shuting Xie, Jiaxing Zhang, et al.. (2020). Changes of Transporters and Drug-metabolizing Enzymes in Nephrotic Syndrome. Current Drug Metabolism. 21(5). 368–378. 8 indexed citations
12.
Zhou, Xuefeng, Zhi Liang, Kunlong Li, et al.. (2019). Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1. Journal of Medicinal Chemistry. 62(15). 7058–7069. 46 indexed citations
13.
Zhou, Fenghua, et al.. (2018). Codonopsis tangshen Oliv. Amelioration Effect on Diabetic Kidney Disease Rats Induced by High Fat Diet Feeding Combined with Streptozotocin. Natural Products and Bioprospecting. 8(6). 441–451. 8 indexed citations
14.
Tang, Lan, et al.. (2012). Study on Metabolism of Aconitine in Liver Microsomes of Guinea Pig and Mice. Zhongguo yaofang. 1 indexed citations
15.
Tang, Lan, et al.. (2011). Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. Toxicology Letters. 202(1). 47–54. 75 indexed citations
16.
Ye, Ling, et al.. (2010). Absorption characteristics of andrographolide in rat intestine in situ. Zhongcaoyao. 41(2). 219–222. 1 indexed citations
17.
Liu, Siyu, et al.. (2010). Application of Microsatellite Makers for Motherless Parentage Testing in Alopex lagopus. 14(3). 133–153. 2 indexed citations
18.
Yang, Zhen, Wei Zhu, Song Gao, et al.. (2010). Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC–MS/MS method: Application to an oral bioavailability study of genistein in mice. Journal of Pharmaceutical and Biomedical Analysis. 53(1). 81–89. 72 indexed citations
19.
Tang, Lan. (2006). ON SILURIAN SHENSIPHYLLUM GE ET Yü, 1974. Gushengwu xuebao. 1 indexed citations
20.
Tang, Lan, et al.. (2006). Early Silurian (Telychian) rugose coral fauna of Daguan area, northeast Yunnan province, China. Frontiers of Biology in China. 1(3). 332–344. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026